Gold mining (CNL) displays gold 442 meters in the APOLLO system in Colombia

Collection Mining Ltd. (NYSE:CNL) He is One of the best Canadian golden stocks for purchase according to hedge funds. On July 21, the company announced results from the APOLLO drilling program in the Guayabales project, located in Caldas, Colombia. This discrimination is the interception of the excavation 442.35 meters at 2.16 grams per ton (g/ton) equivalent to gold starting from the surface, including 68.05 meters in 4.55 g/ton equivalent to gold. The hole (APC-125) bottom while still in a strong dimension.

Fer Gregory/Shutterstock.com

According to the company, the equivalent grades of gold consist of a group of gold, silver, copper and tingstin. For 442.35 meters, the collapse is 1.18 g/ton of gold, 43 g/ton of silver, 0.21 % copper, and 0.05 % wo₃. Another hole (APC-126) recorded 325.10 meters in 2.03 g/ton equivalent to gold (0.98 g/ton of gold, 27 g/ton, copper 0.47 %, and 0.03 % wo₃), starting at 8 meters below the surface.

APOLLO is the most advanced discovery in the multi -goal Guayabales project in collective mining. The company said that it is conducting a 70,000 -meter training program for 2025, and runs ten drilling platforms: eight in Guayabales, and two in San Antonio.

Collection Mining Ltd. (NYSE: CNL) is a Canadian metal exploration company that focuses on developing high -quality golden deposits in Colombia. Its leading origins are the Guayabales project, where the company has reported the results of high -quality drilling, including intersections that exceed 9 g/ton equivalent to gold.

While we acknowledge the capabilities of CNL as an investment, we believe that some artificial intelligence shares provide greater potential in the upward direction and carry less negative risks. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read the following: 12 The best depression shares for purchase in 2025 and The 10 best medical companies of artificial intelligence for purchase according to analysts.

Detection: Nothing. This article was originally published in A monkey from the inside.